Showing results (31-40 of 623) with videos related to
Sort By:
Pageof 63
International Journal of Cardiology|October 1, 1987
Coronary flow reserve and diastolic dysfunction in hypertrophic cardiomyopathyF J Ten Cate, P W SerruysInternational Journal of Clinical Practice|February 24, 2006
Clinical development of bivalirudin (Angiox): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromesP W Serruys, P Vranckx, K AllikmetsCirculation|November 1, 1995
Progression and regression of coronary stenosis in the long-term follow-up of vasospastic anginaY Ozaki, D Keane, P W SerruysEuropean Heart Journal|April 1, 1990
Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trialP J de Feyter, P W SerruysHeart (British Cardiac Society)|March 1, 1996
Relation of basal coronary tone and vasospastic activity in patients with variant anginaY Ozaki, D Keane, P W SerruysCatheterization and Cardiovascular Diagnosis|January 1, 1988
Does intracoronary papaverine dilate epicardial coronary arteries? Implications for the assessment of coronary flow reserveF Zijlstra, J H Reiber, P W SerruysCirculation|March 15, 1996
Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curveK G Lehmann, R Melkert, P W SerruysInternational Journal of Cardiology|June 10, 2000
Vineberg revisited. Long-term survival more than two decades after direct surgical myocardial revascularizationG Van Langenhove, P Serrano, P W SerruysCatheterization and Cardiovascular Diagnosis|January 1, 1986
Papaverine: the ideal coronary vasodilator for investigating coronary flow reserve? A study of timing, magnitude, reproducibility, and safety of the coronary hyperemic response after intracoronary papaverineF Zijlstra, P W Serruys, P G HugenholtzPageof 63